HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Malignant fibrous histiocytoma complicating mitral valve replacement.

Abstract
A 67 year old woman developed a fatal febrile illness 8 years after mitral valve replacement for rheumatic valvular heart disease. The final disease persisted for 1 year and was characterized clinically by weakness, weight loss, congestive heart failure and multiple embolic events to the central nervous system and abdominal organs. The source of the emboli was a tumor, malignant fibrous histiocytoma of the left atrium, originating from the anulus fibrosus around the covered base of the prosthetic valve. This unique case suggests the possibility that chronic exposure to materials, such as Dacron, covering prosthetic valves may induce local malignant tumors.
AuthorsE Holtzman, G Schiby, P Segal, I Priel
JournalJournal of the American College of Cardiology (J Am Coll Cardiol) Vol. 7 Issue 4 Pg. 956-60 (Apr 1986) ISSN: 0735-1097 [Print] United States
PMID3007598 (Publication Type: Case Reports, Journal Article)
Topics
  • Aged
  • Female
  • Heart Atria
  • Heart Failure (etiology)
  • Heart Neoplasms (etiology, pathology)
  • Heart Valve Prosthesis (adverse effects)
  • Histiocytoma, Benign Fibrous (etiology, pathology)
  • Humans
  • Mitral Valve (pathology, surgery)
  • Necrosis
  • Neoplastic Cells, Circulating

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: